• MDS Congress 2026 Session 4206 Evaluation Form

  • Plenary Session 4206

    New Advances in Ataxia

    October 7, 2026

    10:30 - 12:00

  • Learning Objectives:

    1. Describe recent advances in the genetic characterization of pediatric and adult-onset ataxias
    2. Identify key fluid, imaging, and clinical markers for tracking disease progression in ataxias
    3. Describe the molecular and cellular pathways implicated in cerebellar degeneration and discuss how these insights are guiding treatment development

  • Session Evaluation

  • The session met its learning objectives
  • The content is relevant to my professional and / or scientific interests.
  • The quality of the education process (method of presentation and information provided) was satisfactory and appropriate.
  • The information provided will enhance my care of patients with Movement Disorders and / or advance my scientific understanding of Movement Disorders.
  • The overall session organization was satisfactory and appropriate.
  • I would recommend this session to a colleague.

  • Faculty Assessment

  • Bernard Brais, Canada

  • This speaker was able to effectively communicate the content of their presentation
  • The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.

  • Sheng-Han Kuo, USA

  • This speaker was able to effectively communicate the content of their presentation
  • The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.

  • Alexandra Durr, France

  • This speaker was able to effectively communicate the content of their presentation
  • The information was presented without commercial bias. The speaker did not discuss a single branded commercial product or service.
  • The following category best describes your current major professional activity (choose one):

  • Should be Empty: